A new view of diabetic retinopathy: a neurodegenerative disease of the eye

被引:499
作者
Barber, AJ [1 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Coll Med,Penn State Retina Res Grp, Ulerich Ophthalmol Res Ctr, Hershey, PA 17033 USA
关键词
apoptosis; blood-retinal barrier; diabetes; glutamate excitotoxicity; retina;
D O I
10.1016/S0278-5846(03)00023-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Diabetic retinopathy (DR) is a common complication of diabetes and a leading cause of legal blindness in working-age adults. The clinical hallmarks of DR include increased vascular permeability, leading to edema, and endothelial cell proliferation. Much of the research effort has been focused on vascular changes, but it is becoming apparent that other degenerative changes occur beyond the vascular cells of the retina. These include increased apoptosis, glial cell reactivity, microglial activation, and altered glutamate metabolism. When occurring together, these changes may be considered as neurodegenerative and could explain some of the functional deficits in vision that begin soon after the onset of diabetes. This review will present the current evidence that neurodegeneration of the retina is a critical component of DR. There are two basic hypotheses that account for loss of cells in the neural retina. First, the loss of blood-retinal barrier integrity, which initially manifests as an increase in vascular permeability, causes a failure to control the composition of the extracellular fluid in the retina, which in turn leads to edema and neuronal cell loss. Alternatively, diabetes has a direct effect on metabolism within the neural retina, leading to an increase in apoptosis, which in turn causes breakdown of the blood-retinal barrier. It is not clear which hypothesis will be found to be correct, and, in fact, it is likely that vascular permeability and neuronal apoptosis are closely linked components of DR. However, the gradual loss of neurons suggests that progress of the disease is ultimately irreversible, since these cells cannot usually be replaced. In light of this possibility, new treatments for DR should be preventive in nature, being implemented before overt clinical symptoms develop. While vascular permeability is the target that is primarily considered for new treatments of DR, evidence presented here suggests that apoptosis of neurons is also an essential target for pharmacological studies. The vision of people with diabetes will be protected only when we have discovered a means to prevent the gradual but constant loss of neurons within the inner retina. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 93 条
[71]   Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: Effect of glutamate antagonists [J].
Osborne, NN ;
Larsen, AK .
NEUROCHEMISTRY INTERNATIONAL, 1996, 29 (03) :263-270
[72]   Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro [J].
Podestà, F ;
Romeo, G ;
Liu, WH ;
Krajewski, S ;
Reed, JC ;
Gerhardinger, C ;
Lorenzi, M .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :1025-1032
[73]  
Rungger-Brändle E, 2000, INVEST OPHTH VIS SCI, V41, P1971
[74]   DEVELOPMENT OF ELECTRORETINOGRAPHIC ALTERATIONS IN STREPTOZOTOCIN-INDUCED DIABETES IN RATS [J].
SAKAI, H ;
TANI, Y ;
SHIRASAWA, E ;
SHIRAO, Y ;
KAWASAKI, K .
OPHTHALMIC RESEARCH, 1995, 27 (01) :57-63
[75]  
SCOTT TM, 1986, J ANAT, V144, P145
[76]   THE DEVELOPMENT OF ELECTRORETINOGRAM ABNORMALITIES AND THE POSSIBLE ROLE OF POLYOL PATHWAY ACTIVITY IN DIABETIC HYPERGLYCEMIA AND GALACTOSEMIA [J].
SEGAWA, M ;
HIRATA, Y ;
FUJIMORI, S ;
OKADA, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (05) :454-460
[77]   Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy - A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy [J].
Segawa, Y ;
Shirao, Y ;
Yamagishi, S ;
Higashide, T ;
Kobayashi, M ;
Katsuno, K ;
Iyobe, A ;
Harada, H ;
Sato, F ;
Miyata, H ;
Asai, H ;
Nishimura, A ;
Takahira, M ;
Souno, T ;
Segawa, Y ;
Maeda, K ;
Shima, K ;
Mizuno, A ;
Yamamoto, H ;
Kawasaki, K .
OPHTHALMIC RESEARCH, 1998, 30 (06) :333-339
[78]  
SIMONSEN SE, 1980, ACTA OPHTHALMOL, V58, P865
[79]  
SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51
[80]   Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system [J].
Sondell, M ;
Lundborg, G ;
Kanje, M .
JOURNAL OF NEUROSCIENCE, 1999, 19 (14) :5731-5740